Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Related Concept Videos

Myasthenia Gravis: Diagnostic Tests

Myasthenia Gravis: Diagnostic Tests

Myasthenia gravis is an autoimmune condition affecting neuromuscular transmission, causing generalized weakness in skeletal muscles. Initial diagnoses rely on patients' signs, symptoms, and medical history. The challenge lies in distinguishing myasthenia from other muscular dystrophies. An important diagnostic feature is the significant improvement of symptoms after administering anticholinesterase inhibitors.
The edrophonium test is a diagnostic tool for myasthenia gravis. It involves...

Myasthenia Gravis: Overview and Treatment

Myasthenia Gravis: Overview and Treatment

Myasthenia gravis is a neuromuscular transmission disorder characterized by weakness and increased fatigability of skeletal muscles. It is an autoimmune disease affecting approximately one in 2000 people, where antibodies against the α1 subunit of nicotinic acetylcholine receptors are produced.
These antibodies interfere with the function of the nicotinic receptors in three ways: by binding to the receptor and disrupting acetylcholine binding; by causing cross-linking of receptors which leads...

Myasthenia Gravis ll: Pathophysiology

Myasthenia Gravis ll: Pathophysiology

The disease process of myasthenia gravis begins at the neuromuscular junction, where antibodies attack key proteins needed for muscle activation. This immune reaction weakens signal transmission, leading to the characteristic muscle fatigue and weakness that define the condition.Immune-Mediated DamageIn most individuals, antibodies target acetylcholine receptors (AChRs) on the postsynaptic membrane of muscle cells. By blocking acetylcholine binding, these antibodies prevent the nerve signal...

Disorders of the Skeletal Muscle

Disorders of the Skeletal Muscle

The clinical conditions affecting the skeletal muscle tissue are broadly categorized as musculoskeletal and neuromuscular disorders.
Musculoskeletal disorders
Musculoskeletal disorders involve injuries and conditions affecting the skeletal muscles and associated connective tissues. These disorders can arise from acute biomechanical stresses or chronic overuse and can occur across different age groups. Common injuries include sprains, fractures, and muscular strains, often resulting from...

Graves' Disease I: Introduction

Graves' Disease I: Introduction

Graves' disease is an autoimmune disorder that causes hyperthyroidism, or overactivity of the thyroid gland. It results from autoantibodies called thyroid-stimulating immunoglobulins (TSIs), which bind to thyroid-stimulating hormone (TSH) receptors, leading to overstimulation of hormone production and a hypermetabolic state.EtiologyAlthough considered idiopathic, Graves’ disease has well-established contributing factors. There is a strong genetic component, with increased prevalence in...

Graves Disease II: Pathophysiology

Graves Disease II: Pathophysiology

Graves’ disease is an autoimmune disorder characterized by the production of thyroid-stimulating immunoglobulins (TSI) that activate TSH receptors, leading to excessive synthesis and release of thyroid hormones (T3 and T4) and resulting in hyperthyroidism.Among all causes of hyperthyroidism, Graves’ disease is the most common and can happen at any age, though it is more frequent in women. It produces a hypermetabolic state with features such as weight loss, tachycardia, tremor, and heat...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

[Recommendations for the use of neurophysiological techniques in the diagnosis of brain death from the Clinical Neurophysiology Society of the Communities of Valencia and Murcia].

Revista de neurologia·2022

Same author

[Cognitive-behavioural group therapy for insomnia: evaluation of the results after its implementation in a health department].

Revista de neurologia·2020

Same author

Status dissociatus: The most extreme expression of state dissociation.

Neurologia·2017

Same author

Sodium oxybate and modafinil: a good combination?

Sleep medicine·2010

Same author

[Chronic compartment syndrome due to exercise with bilateral gluteal denervation].

Revista de neurologia·2009

Same author

[Frontal absences and 'pseudo-absences'].

Revista de neurologia·2008

Search research articles

Related Experiment Video

Updated: Jul 15, 2026

Engineering and Characterization of an Optogenetic Model of the Human Neuromuscular Junction

Engineering and Characterization of an Optogenetic Model of the Human Neuromuscular Junction

Published on: April 14, 2022

[Ocular myasthenia gravis: diagnostic aspects and evolution].

M de Entrambasaguas¹, R López-Bernabé, M López-Alemany

¹Servicio de Neurofisiología Clínica, Hospital General de Castellón, 12004 Castellón de la Plana, España. entrambasaguas_man@gva.es

Revista De Neurologia

|April 11, 2007

Summary

Ocular myasthenia gravis (OMG) diagnosis is challenging. High-sensitivity tests like SFEMG jitter are crucial for early detection and differentiating OMG from other conditions causing ptosis or diplopia.

Related Experiment Videos

Last Updated: Jul 15, 2026

Engineering and Characterization of an Optogenetic Model of the Human Neuromuscular Junction

Engineering and Characterization of an Optogenetic Model of the Human Neuromuscular Junction

Published on: April 14, 2022

Area of Science:

Neurology
Ophthalmology
Clinical Diagnostics

Context:

Myasthenia gravis diagnosis lacks a gold standard, relying on multiple tests.
Ocular myasthenia gravis (OMG) can progress to generalized disease early.
Differentiating OMG from other causes of ptosis and diplopia is clinically significant.

Purpose:

To compare clinical data and diagnostic test findings in OMG versus other diagnoses.
To determine the conversion rate of OMG to generalized myasthenia.
To evaluate the diagnostic performance of various tests for OMG.

Summary:

A retrospective study of 44 patients suspected of OMG found 12 (27%) diagnosed with OMG.
OMG patients presented with ptosis/diplopia more frequently than isolated diplopia.
SFEMG jitter demonstrated 100% sensitivity in OMG patients, outperforming other tests.

Impact:

Early and accurate diagnosis of OMG is essential for timely management.
High-sensitivity testing, particularly SFEMG jitter, improves diagnostic yield for OMG.
Understanding conversion rates aids in monitoring and predicting disease progression.